Tag: biolinerx

November 22, 2016

BioLineRx Reports Q3 2016 Financial Results

BioLineRx today announced its financial results for the third quarter of 2016, which ended on September 30, 2016.
September 9, 2016

BioLineRx Hosts Investor Meeting

BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it will...
March 23, 2016

BioLineRx Initiates Phase 2 Trial for BL-8040 as Novel Stem Cell Mobilization Treatment

BioLineRx Ltd. (NASDAQ:BLRX) announced the initiation of a Phase 2 trial for BL-8040 as a novel approach for the mobilization...